ERBB2 and breast cancer: BC is a highly heterogeneous disease, clinically divided into three broad subgroups: hormone receptor-positive (that express receptors for estrogen and progesterone), human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative breast cancer (TNBC), that lacks all of these receptors.